Acute γ-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer's disease

…, G Diamantidis, X Gong, H Zhou, AF Kreft… - Journal of …, 2005 - Soc Neuroscience
Transgenic mice (Tg2576) overexpressing the Swedish mutation of the human amyloid
precursor protein display biochemical, pathological, and behavioral markers consistent with …

Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein γ-secretase for the treatment of Alzheimer's disease

…, JZ Xu, X Huang, X Gong, M Jin, A Kreft… - … of Pharmacology and …, 2009 - ASPET
The presenilin containing γ-secretase complex is responsible for the regulated
intramembraneous proteolysis of the amyloid precursor protein (APP), the Notch receptor, and a …

Discovery of begacestat, a Notch-1-sparing γ-secretase inhibitor for the treatment of Alzheimer's disease

SC Mayer, AF Kreft, B Harrison… - Journal of medicinal …, 2008 - ACS Publications
SAR on HTS hits 1 and 2 led to the potent, Notch-1-sparing GSI 9, which lowered brain Aβ
in Tg2576 mice at 100 mg/kg po. Converting the metabolically labile methyl groups in 9 to …

Recent advances in the identification of γ-secretase inhibitors to clinically test the Aβ oligomer hypothesis of Alzheimer's disease

AF Kreft, R Martone, A Porte - Journal of medicinal chemistry, 2009 - ACS Publications
Alzheimer’s disease (ADa) was first described over a hundred years ago by Alois Alzheimer
as a dementia associated with the presence of extracellular insoluble β-amyloid plaques in …

Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1

…, K O'Neill, D Hartman, R Carlson, A Kreft… - European journal of …, 1995 - Elsevier
The isozymes of prostaglandin G/H synthase (PGHS) are shown to be differentially inhibited
in vitro by currently marketed nonsteroidal anti-inflammatory drugs (NSAIDs) using …

5-lipoxygenase: properties, pharmacology, and the quinolinyl (bridged) aryl class of inhibitors

JH Musser, AF Kreft - Journal of medicinal chemistry, 1992 - ACS Publications
Feldberg, Kellaway, and Trethewie12 a half century ago first recognized that stimulated
lung tissue can produce a material, SRS-A (slow reacting substance of anaphylaxis), which …

Inhibition of platelet and neutrophil phospholipase A2 by hydroxyeicosatetraenoic acids (HETEs) A novel pharmacological mechanism for regulating free fatty acid …

J Chang, E Blazek, AF Kreft, AJ Lewis - Biochemical pharmacology, 1985 - Elsevier
The present study demonstrated that acid-extracted platelet phospholipase A 2 (PLA 2 )
exhibited marked hydrolytic activity against both [1- 14 C]oleic acid- and [1- 14 C]arachidonic …

N-[(Arylmethoxy) phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides. Potent orally active leukotriene D4 antagonists of novel structure

JH Musser, AF Kreft, RHW Bender… - Journal of medicinal …, 1990 - ACS Publications
N-[(Arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl
carboxamides. Potent orally active leukotri Page 1 240 J. Med. Chem. 33, 240-245 JV-[(Arylmethoxy)…

Practical enantioselective synthesis of a 3-aryl-3-trifluoromethyl-2-aminopropanol derivative

…, S Tadayon, DM Springer, AF Kreft… - … Process Research & …, 2009 - ACS Publications
Development of a large-scale enantioselective synthesis of a lead compound containing a 3-aryl-3-trifluoromethyl-2-aminopropanol
core is described. A single isomer of 3,3-…

Discovery of a novel series of Notch-sparing γ-secretase inhibitors

A Kreft, B Harrison, S Aschmies, K Atchison… - Bioorganic & medicinal …, 2008 - Elsevier
Using a cell-based assay, we have identified a new series of Notch-sparing γ-secretase
inhibitors from HTS screening leads 2a and 2e. Lead optimization studies led to the discovery of …